A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: Obesity Interventions: Drug: CagriSema (Cagrilintide B + semaglutide I); Behavioral: Low Energy Diet Sponsors: Novo Nordisk A/S Not yet recruiting Conditions: Obesity Interventions: Drug: CagriSema (Cagrilintide B + semaglutide I); Behavioral: Low Energy...

Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: CARES; Standard of Care Interventions: Behavioral: CARES; Behavioral: Standard of Care (SOC) Sponsors: University of Pittsburgh; National Cancer Institute (NCI) Recruiting Conditions: CARES; Standard of Care Interventions: Behavioral: CARES; Behavioral:...

Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: HIV Infections Interventions: Biological: HIV Therapeutic Biologic Mix – HIV GP120 plus HIV GP41 plus BCG Vaccine Mix for percutaneous use Sponsors: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair; UnitedHealthcare Active, not...

Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet recruiting Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet...

Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc. Completed Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc....